Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Monkeypox and Other Poxvirus Articles
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Monkeypox and Other Poxvirus Articles
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

February 1, 1983; Volume 130,Issue 2
  • You have accessRestricted access
    Immunoglobulin idiotype and anti-anti-idiotype utilize the same variable region genes irrespective of antigen specificity.
    M N Margolies, L J Wysocki and V L Sato
    J Immunol February 1, 1983, 130 (2) 515-517;
  • You have accessRestricted access
    In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing.
    T W Williams and J A Bellanti
    J Immunol February 1, 1983, 130 (2) 518-520;
  • You have accessRestricted access
    Isotype-specific suppression of IgA: suppression of IgA responses in BALB/c mice by T alpha cells.
    R G Hoover and R G Lynch
    J Immunol February 1, 1983, 130 (2) 521-523;
  • You have accessRestricted access
    A human large granular lymphocyte clone with natural killer-like activity and T cell-like surface markers.
    M J Sheehy, F B Quintieri, D Y Leung, R S Geha, D P Dubey, C E Limmer and E J Yunis
    J Immunol February 1, 1983, 130 (2) 524-526;
  • You have accessRestricted access
    Regulatory mechanisms in cytotoxic T lymphocyte development. I. A suppressor T cell subset that regulates the proliferative stage of CTL development.
    B M Susskind, V J Merluzzi, R B Faanes, M A Palladino and Y S Choi
    J Immunol February 1, 1983, 130 (2) 527-532;
  • You have accessRestricted access
    In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
    S C Gautam, M L Hilfiker and J R Battisto
    J Immunol February 1, 1983, 130 (2) 533-537;
  • You have accessRestricted access
    Characterization of a "heteroclitic" cytotoxic lymphocyte clone: heterogeneity of receptors or signals?
    J H Russell and C B Dobos
    J Immunol February 1, 1983, 130 (2) 538-541;
  • You have accessRestricted access
    Helper cell-independent cytolytic T lymphocytes specific for a minor histocompatibility antigen.
    D C Roopenian, M B Widmer, C G Orosz and F H Bach
    J Immunol February 1, 1983, 130 (2) 542-545;
  • You have accessRestricted access
    Stimulator cell requirements for allospecific T cell subsets: specialized accessory cells are required to activate helper but not cytolytic T lymphocyte precursors.
    A A Czitrom, G H Sunshine, T Reme, R Ceredig, A L Glasebrook, A Kelso and H R MacDonald
    J Immunol February 1, 1983, 130 (2) 546-550;
  • You have accessRestricted access
    Activation of lymphocytes by a thiol-derivatized nucleoside: characterization of cellular parameters and responsive subpopulations.
    M G Goodman and W O Weigle
    J Immunol February 1, 1983, 130 (2) 551-557;
  • You have accessRestricted access
    Intramucosal lymphocytes of the gut: Lyt-2 and thy-1 phenotype of the granulated cells and evidence for the presence of both T cells and mast cell precursors.
    J W Schrader, R Scollay and F Battye
    J Immunol February 1, 1983, 130 (2) 558-564;
  • You have accessRestricted access
    Expression of cell surface antigens by suppressor T cell hybridomas. I. Comparison of phenotype and function.
    J Trial, J A Kapp, C W Pierce, D C Shreffler, C M Sorensen and C Waltenbaugh
    J Immunol February 1, 1983, 130 (2) 565-572;
  • You have accessRestricted access
    Immune response to the p-azobenzenearsonate (ABA)-GAT conjugate. II. Hapten-specific T cells induced with ABA-GAT in GAT responder X nonresponder F1 hybrids are restricted to the nonresponder haplotype.
    D Regnier and M Seman
    J Immunol February 1, 1983, 130 (2) 573-578;
  • You have accessRestricted access
    Hapten-specific T cell response to azobenzenearsonate-N-acetyl-L-tyrosine in the Lewis rat. II. Induction of helper activity demonstrated by TNP-haptenated ABA-peptide-Ficoll.
    T Komatsu, A Amsden, C Y Lawn and S Leskowitz
    J Immunol February 1, 1983, 130 (2) 579-585;
  • You have accessRestricted access
    Hapten-specific T cell response to azobenzenearsonate-N-acetyl-L-tyrosine in the Lewis rat. III. Effects of peptide-spacer structure on eliciting ABA-specific helper activity with TNP-haptened ABA-peptide-Ficoll.
    T Komatsu, C Y Lawn, A Amsden and S Leskowitz
    J Immunol February 1, 1983, 130 (2) 586-589;
  • You have accessRestricted access
    Idiotype shifts caused by neonatal tolerance to phosphorylcholine.
    J Quintáns and Z S Quan
    J Immunol February 1, 1983, 130 (2) 590-595;
  • You have accessRestricted access
    Mechanisms of idiotype suppression. V. Anti-idiotype antibody inhibits early B cell triggering induced by antigen.
    B S Kim, P B Massey and K M Hui
    J Immunol February 1, 1983, 130 (2) 596-601;
  • You have accessRestricted access
    Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies.
    N E Phillips and D C Parker
    J Immunol February 1, 1983, 130 (2) 602-606;
  • You have accessRestricted access
    Activation of antigen-enriched b cells. I. Purification and response to thymus-independent antigens.
    E C Snow, E S Vitetta and J W Uhr
    J Immunol February 1, 1983, 130 (2) 607-613;
  • You have accessRestricted access
    Activation of antigen-enriched B cells. II. Role of linked recognition in B cell proliferation to thymus-dependent antigens.
    E C Snow, R J Noelle, J W Uhr and E S Vitetta
    J Immunol February 1, 1983, 130 (2) 614-618;
  • You have accessRestricted access
    The ontogeny and distribution of B cells in normal and mutant immune-defective CBA/N mice: two-parameter analysis of surface IgM and IgD.
    I Scher, J A Titus and F D Finkelman
    J Immunol February 1, 1983, 130 (2) 619-625;
  • You have accessRestricted access
    Level of mIa expression on mitogen-stimulated murine B lymphocytes is dependent on position in cell cycle.
    J G Monroe and J C Cambier
    J Immunol February 1, 1983, 130 (2) 626-631;
  • You have accessRestricted access
    Analysis of the B cell subpopulations influenced by allogeneic effect factor. I. MHC restricted enhancement of b cell responses to thymic-independent antigens, types 1 and 2, in normal and CBA/N mice.
    L J Yaffe, J J Mond, A Ahmed and I Scher
    J Immunol February 1, 1983, 130 (2) 632-636;
  • You have accessRestricted access
    Functional differentiation in the genetic control of murine T lymphocyte responses to human fibrinopeptide B.
    L B Peterson, G D Wilner and D W Thomas
    J Immunol February 1, 1983, 130 (2) 637-643;
  • You have accessRestricted access
    Regulation of lymphocyte production in the bone marrow. I. Turnover of small lymphocytes in mice depleted of B lymphocytes by treatment with anti-IgM antibodies.
    G Fulop, J Gordon and D G Osmond
    J Immunol February 1, 1983, 130 (2) 644-648;
  • You have accessRestricted access
    IgE-binding factors from mouse T lymphocytes. I. Formation of IgE-binding factors by stimulation with homologous IgE and interferon.
    T Uede, K Sandberg, B R Bloom and K Ishizaka
    J Immunol February 1, 1983, 130 (2) 649-654;
  • You have accessRestricted access
    Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
    L P de Waal, J de Hoop, M J Stukart, H Gleichmann, R W Melvold and C J Melief
    J Immunol February 1, 1983, 130 (2) 655-660;
  • You have accessRestricted access
    Bone marrow-derived macrophage as accessory cells in antigen-induced T cell proliferation. H-2I region requirements for L-glutamic60-L-alanine30-L-tyrosine10 response.
    L B Schook, P M Allen and J E Niederhuber
    J Immunol February 1, 1983, 130 (2) 661-664;
  • You have accessRestricted access
    Phenotypic characteristics of peripheral blood T cells regulating colony growth by nontransformed human B lymphocytes.
    R L Whisler, K J Wajda and Y G Newhouse
    J Immunol February 1, 1983, 130 (2) 665-670;
  • You have accessRestricted access
    IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.
    M Mayumi, T Kuritani, H Kubagawa and M D Cooper
    J Immunol February 1, 1983, 130 (2) 671-677;
  • You have accessRestricted access
    Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen.
    M Peters and A S Fauci
    J Immunol February 1, 1983, 130 (2) 678-680;
  • You have accessRestricted access
    The effect of alpha 1 antitrypsin on the proliferative response of human peripheral blood lymphocytes.
    S N Breit, E Luckhurst and R Penny
    J Immunol February 1, 1983, 130 (2) 681-686;
  • You have accessRestricted access
    Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    B M Vose and G D Bonnard
    J Immunol February 1, 1983, 130 (2) 687-693;
  • You have accessRestricted access
    Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans.
    B Crary, M Borysenko, D C Sutherland, I Kutz, J Z Borysenko and H Benson
    J Immunol February 1, 1983, 130 (2) 694-697;
  • You have accessRestricted access
    Functional subsets of human monocytes defined by monoclonal antibodies: a distinct subset of monocytes contains the cells capable of inducing the autologous mixed lymphocyte culture.
    H H Shen, M A Talle, G Goldstein and L Chess
    J Immunol February 1, 1983, 130 (2) 698-705;
  • You have accessRestricted access
    Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
    T A Gonwa, L J Picker, H V Raff, S M Goyert, J Silver and J D Stobo
    J Immunol February 1, 1983, 130 (2) 706-711;
  • You have accessRestricted access
    Cellular interactions in marrow-grafted patients. I. Impairment of cell-mediated lympholysis associated with graft-vs-host disease and the effect of interleukin 2.
    T Mori, M S Tsoi, S Gillis, E Santos, E D Thomas and R Storb
    J Immunol February 1, 1983, 130 (2) 712-716;
  • You have accessRestricted access
    Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
    A D Hess, A D Donnenberg, P J Tutschka and G W Santos
    J Immunol February 1, 1983, 130 (2) 717-721;
  • You have accessRestricted access
    Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.
    R C Aalberse, R van der Gaag and J van Leeuwen
    J Immunol February 1, 1983, 130 (2) 722-726;
  • You have accessRestricted access
    Antigens of Ambrosia elatior (short ragweed) pollen. III. Crossed radioimmunoelectrophoresis of ragweed-allergic patients' sera with special attention to quantification of IgE responses.
    H Løwenstein and D G Marsh
    J Immunol February 1, 1983, 130 (2) 727-731;
  • You have accessRestricted access
    Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    J H Holda, D Silberg and R H Swanborg
    J Immunol February 1, 1983, 130 (2) 732-734;
  • You have accessRestricted access
    Fc dependence of macrophage accumulation and subsequent injury in experimental glomerulonephritis.
    S R Holdsworth
    J Immunol February 1, 1983, 130 (2) 735-739;
  • You have accessRestricted access
    Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.
    N Maruyama, F Furukawa, Y Nakai, Y Sasaki, K Ohta, S Ozaki, S Hirose and T Shirai
    J Immunol February 1, 1983, 130 (2) 740-746;
  • You have accessRestricted access
    Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
    T R Malek, R J Robb and E M Shevach
    J Immunol February 1, 1983, 130 (2) 747-755;
  • You have accessRestricted access
    Characterization of helper factors distinct from interleukin 2 necessary for the generation of allospecific cytolytic T lymphocytes.
    R D Garman and D P Fan
    J Immunol February 1, 1983, 130 (2) 756-762;
  • You have accessRestricted access
    Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.
    J H Finke, J Scott, S Gillis and M L Hilfiker
    J Immunol February 1, 1983, 130 (2) 763-767;
  • You have accessRestricted access
    Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors.
    B M Vose, C Riccardi, G D Bonnard and R B Herberman
    J Immunol February 1, 1983, 130 (2) 768-772;
  • You have accessRestricted access
    Staphylococcus aureus protein A induces the production of interferon-alpha in human lymphocytes and interferon-alpha/beta in mouse spleen cells.
    E M Smith, H M Johnson and J E Blalock
    J Immunol February 1, 1983, 130 (2) 773-776;
  • You have accessRestricted access
    Soluble factors for B cell activation: a T cell hybridoma that secretes a specific B cell growth factor.
    H J Garchon, M Levi-Strauss, C Carnaud and J F Bach
    J Immunol February 1, 1983, 130 (2) 777-780;
  • You have accessRestricted access
    A requirement for nonspecific T cell factors in antibody responses to "T cell independent" antigens.
    R O Endres, E Kushnir, J W Kappler, P Marrack and S C Kinsky
    J Immunol February 1, 1983, 130 (2) 781-784;
  • You have accessRestricted access
    Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.
    M Malkovský, G L Asherson, P Chandler, V Colizzi, M C Watkins and M Zembala
    J Immunol February 1, 1983, 130 (2) 785-790;
  • You have accessRestricted access
    Thymosin peptides and lymphokines do not directly stimulate adrenal corticosteroid production in vitro.
    G V Vahouny, E Kyeyune-Nyombi, J P McGillis, N S Tare, K Y Huang, R Tombes, A L Goldstein and N R Hall
    J Immunol February 1, 1983, 130 (2) 791-794;
  • You have accessRestricted access
    Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.
    M A Vadas, N A Nicola and D Metcalf
    J Immunol February 1, 1983, 130 (2) 795-799;
  • You have accessRestricted access
    The synthesis and secretion of granulocyte-monocyte colony-stimulating activity (CSA) by isolated human monocytes: kinetics of the response to bacterial endotoxin.
    R Sullivan, P J Gans and L A McCarroll
    J Immunol February 1, 1983, 130 (2) 800-807;
  • You have accessRestricted access
    The extracellular region of light chains from human and murine MHC class II antigens consists of two domains.
    J F Kaufman and J L Strominger
    J Immunol February 1, 1983, 130 (2) 808-817;
  • You have accessRestricted access
    Isoelectric focusing of human anti-diphtheria toxoid antibodies: identical spectrotypes of anti-fragment A antibodies with the same IgG subclass and light chain constant regions are expressed in multiple individuals.
    C D Morrow, F Dorey and R H Stevens
    J Immunol February 1, 1983, 130 (2) 818-823;
  • You have accessRestricted access
    A newly defined murine alloantigen controlled by the S region of the H-2 complex: molecular association with the fourth component of complement.
    D G Spinella and H C Passmore
    J Immunol February 1, 1983, 130 (2) 824-828;
  • You have accessRestricted access
    Immune enhancement in mice by ara-A.
    J Hinrichs, D Kitz, G Kobayashi and J R Little
    J Immunol February 1, 1983, 130 (2) 829-833;
  • You have accessRestricted access
    Biosynthesis of C4 by mouse peritoneal macrophages. II. Comparison of C4 synthesis by resident and elicited cell populations.
    S L Newell and J P Atkinson
    J Immunol February 1, 1983, 130 (2) 834-838;
  • You have accessRestricted access
    Cell volume and osmotic properties of erythrocytes after complement lysis measured by flow cytometry.
    J Bauer and G Valet
    J Immunol February 1, 1983, 130 (2) 839-844;
  • You have accessRestricted access
    Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    K Joiner, E Brown, C Hammer, K Warren and M Frank
    J Immunol February 1, 1983, 130 (2) 845-849;
  • You have accessRestricted access
    Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity.
    D English and J N Lukens
    J Immunol February 1, 1983, 130 (2) 850-856;
  • You have accessRestricted access
    Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity.
    C Dahinden, C Galanos and J Fehr
    J Immunol February 1, 1983, 130 (2) 857-862;
  • You have accessRestricted access
    Granulocyte activation by endotoxin. II. Role of granulocyte adherence, aggregation, and effect of cytochalasin B, and comparison with formylated chemotactic peptide-induced stimulation.
    C Dahinden and J Fehr
    J Immunol February 1, 1983, 130 (2) 863-868;
  • You have accessRestricted access
    Hormonal activation of adenylate cyclase in macrophage membranes is regulated by guanine nucleotides.
    M W Verghese and R Snyderman
    J Immunol February 1, 1983, 130 (2) 869-873;
  • You have accessRestricted access
    C3 cleavage products stimulate release of prostaglandins by human mononuclear phagocytes in vitro.
    B Rutherford and H A Schenkein
    J Immunol February 1, 1983, 130 (2) 874-877;
  • You have accessRestricted access
    Modulation of the biologic activities of IgE-binding factors. I. Identification of glycosylation-inhibiting factor as a fragment of lipomodulin.
    T Uede, F Hirata, M Hirashima and K Ishizaka
    J Immunol February 1, 1983, 130 (2) 878-884;
  • You have accessRestricted access
    Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation.
    R F Mortensen, K Beisel, N J Zeleznik and P T Le
    J Immunol February 1, 1983, 130 (2) 885-889;
  • You have accessRestricted access
    Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1.
    C A Dinarello, S O Marnoy and L J Rosenwasser
    J Immunol February 1, 1983, 130 (2) 890-895;
  • You have accessRestricted access
    Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region.
    V A Fischetti
    J Immunol February 1, 1983, 130 (2) 896-902;
  • You have accessRestricted access
    Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice.
    L Nencioni, L Villa, D Boraschi, B Berti and A Tagliabue
    J Immunol February 1, 1983, 130 (2) 903-907;
  • You have accessRestricted access
    Inhibition of mitogen-induced proliferation of mouse T and B lymphocytes by bloodstream forms of Trypanosoma cruzi.
    J R Maleckar and F Kierszenbaum
    J Immunol February 1, 1983, 130 (2) 908-911;
  • You have accessRestricted access
    Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus.
    M B Oldstone, A Tishon and M J Buchmeier
    J Immunol February 1, 1983, 130 (2) 912-918;
  • You have accessRestricted access
    An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
    C M Edson, L K Cohen, W Henle and J L Strominger
    J Immunol February 1, 1983, 130 (2) 919-924;
  • You have accessRestricted access
    Pichinde virus-specific cell-associated suppression of primary footpad swelling in an inbred strain of Syrian hamsters.
    M Chan, D Clark and W E Rawls
    J Immunol February 1, 1983, 130 (2) 925-931;
  • You have accessRestricted access
    Maternal-infant transfer of influenza-specific immunity in the mouse.
    P D Reuman, C M Paganini, E M Ayoub and P A Small Jr
    J Immunol February 1, 1983, 130 (2) 932-936;
  • You have accessRestricted access
    Anti-oxazolone hybridomas and the structure of the oxazolone idiotype.
    M Kaartinen, G M Griffiths, P H Hamlyn, A F Markham, K Karjalainen, J L Pelkonen, O Mäkelä and C Milstein
    J Immunol February 1, 1983, 130 (2) 937-945;
  • You have accessRestricted access
    A new lymphocyte cell surface antigen, Ly-22.2, controlled by a locus on chromosome 4 and a second unlinked locus.
    D Meruelo, M Offer and N Flieger
    J Immunol February 1, 1983, 130 (2) 946-950;
  • You have accessRestricted access
    Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    P S Russell, C M Chase and R C Burton
    J Immunol February 1, 1983, 130 (2) 951-957;
  • You have accessRestricted access
    Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin.
    A Mazumder, E A Grimm and S A Rosenberg
    J Immunol February 1, 1983, 130 (2) 958-964;
  • You have accessRestricted access
    5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    E Lotzová, C A Savary and D A Stringfellow
    J Immunol February 1, 1983, 130 (2) 965-969;
  • You have accessRestricted access
    Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation.
    F K Stevenson and J Gordon
    J Immunol February 1, 1983, 130 (2) 970-973;
  • You have accessRestricted access
    Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    N Hanna and M Schneider
    J Immunol February 1, 1983, 130 (2) 974-980;
  • You have accessRestricted access
    Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    R Suzuki, K Handa, K Itoh and K Kumagai
    J Immunol February 1, 1983, 130 (2) 981-987;
  • You have accessRestricted access
    Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.
    K Handa, R Suzuki, H Matsui, Y Shimizu and K Kumagai
    J Immunol February 1, 1983, 130 (2) 988-992;
  • You have accessRestricted access
    Influence of dietary restriction and aging on natural killer cell activity in mice.
    R Weindruch, B H Devens, H V Raff and R L Walford
    J Immunol February 1, 1983, 130 (2) 993-996;
  • You have accessRestricted access
    Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen.
    R H Carter, J A Drebin, S Schatten, L L Perry and M I Greene
    J Immunol February 1, 1983, 130 (2) 997-1002;
  • You have accessRestricted access
    Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.
    L F Lee, X Liu and R L Witter
    J Immunol February 1, 1983, 130 (2) 1003-1006;
  • You have accessRestricted access
    A monoclonal antibody reactive with Marek's disease tumor-associated surface antigen.
    L F Lee, X Liu, J M Sharma, K Nazerian and L D Bacon
    J Immunol February 1, 1983, 130 (2) 1007-1011;

ERRATA

  • You have accessRestricted access
    Hybridomas specific for carbohydrates; synthetic human blood group antigens for the production, selection, and characterization of monoclonal typing reagents
    DR Bundle, MAJ Gidney, N Kassam and AFR Rahman
    J Immunol February 1, 1983, 130 (2) 1014;
  • You have accessRestricted access
    Antitumor activity and hydrogen peroxide release by macrophages elicited by trehalose diesters
    M Lepoivre, JP Tenu, G Lemaire, JF Petit, EC Lawrence, HW McClune, RK Wilson, MM Key, RM Dodson and GA Hurst
    J Immunol February 1, 1983, 130 (2) 1014;
  • You have accessRestricted access
    Alteration of in vitro immunoglobulin secretion by amosite asbestos
    EC Lawrence
    J Immunol February 1, 1983, 130 (2) 1014;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 130, Issue 2
1 Feb 1983
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ERRATA
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606